These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 26050379)

  • 21. Sexual health needs of female sex workers in Côte d'Ivoire: a mixed-methods study to prepare the future implementation of pre-exposure prophylaxis (PrEP) for HIV prevention.
    Becquet V; Nouaman M; Plazy M; Masumbuko JM; Anoma C; Kouame S; Danel C; Eholie SP; Larmarange J;
    BMJ Open; 2020 Jan; 10(1):e028508. PubMed ID: 31919122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PrEP rollout in Africa: status and opportunity.
    Irungu EM; Baeten JM
    Nat Med; 2020 May; 26(5):655-664. PubMed ID: 32405065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: Results from a prospective observational demonstration project.
    Eakle R; Gomez GB; Naicker N; Bothma R; Mbogua J; Cabrera Escobar MA; Saayman E; Moorhouse M; Venter WDF; Rees H;
    PLoS Med; 2017 Nov; 14(11):e1002444. PubMed ID: 29161256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Barriers and facilitators to pre-exposure prophylaxis uptake among male sex workers in Mexico: an application of the RE-AIM framework.
    Kadiamada-Ibarra H; Hawley NL; Sosa-Rubí SG; Wilson-Barthes M; Franco RR; Galárraga O
    BMC Public Health; 2021 Nov; 21(1):2174. PubMed ID: 34837988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Scaling-up PrEP Delivery in Sub-Saharan Africa: What Can We Learn from the Scale-up of ART?
    O'Malley G; Barnabee G; Mugwanya K
    Curr HIV/AIDS Rep; 2019 Apr; 16(2):141-150. PubMed ID: 30796608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Understanding user perspectives of and preferences for oral PrEP for HIV prevention in the context of intervention scale-up: a synthesis of evidence from sub-Saharan Africa.
    Eakle R; Weatherburn P; Bourne A
    J Int AIDS Soc; 2019 Jul; 22 Suppl 4(Suppl Suppl 4):e25306. PubMed ID: 31328429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A stepped-wedge randomized trial and qualitative survey of HIV pre-exposure prophylaxis uptake in the Eswatini population.
    Geldsetzer P; Bärnighausen K; Hettema A; McMahon SA; Dalal S; Chase RP; Oldenburg CE; Kohler S; Chen S; Dlamini P; Mavuso M; Hughey AB; Matse S; Bärnighausen T
    Sci Transl Med; 2020 Sep; 12(562):. PubMed ID: 32967974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring acceptability of oral PrEP prior to implementation among female sex workers in South Africa.
    Eakle R; Bourne A; Mbogua J; Mutanha N; Rees H
    J Int AIDS Soc; 2018 Feb; 21(2):. PubMed ID: 29457868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV pre-exposure prophylaxis for female sex workers: ensuring women's family planning needs are not left behind.
    Bowring AL; Ampt FH; Schwartz S; Stoové MA; Luchters S; Baral S; Hellard M
    J Int AIDS Soc; 2020 Feb; 23(2):e25442. PubMed ID: 32064765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. "The Drug Will Help Protect My Tomorrow": Perceptions of Integrating PrEP into HIV Prevention Behaviors Among Female Sex Workers in Lilongwe, Malawi.
    Shea J; Bula A; Dunda W; Hosseinipour MC; Golin CE; Hoffman IF; Miller WC; Go VF; Lungu T; Lancaster KE
    AIDS Educ Prev; 2019 Oct; 31(5):421-432. PubMed ID: 31550194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of mHealth use in promoting adherence to pre-exposure prophylaxis among female sex workers: an evaluation of the Jichunge intervention in Dar es Salaam, Tanzania.
    Mbotwa C; Kazaura M; Moen K; Leshabari M; Metta E; Leyna G; Mmbaga EJ
    BMC Health Serv Res; 2022 Jul; 22(1):859. PubMed ID: 35787285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Designing PrEP and early HIV treatment interventions for implementation among female sex workers in South Africa: developing and learning from a formative research process.
    Eakle R; Mutanha N; Mbogua J; Sibanyoni M; Bourne A; Gomez G; Venter F; Rees H
    BMJ Open; 2018 Jun; 8(6):e019292. PubMed ID: 29903784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Community PrEP Study: a randomized control trial leveraging community-based platforms to improve access and adherence to pre-exposure prophylaxis to prevent HIV among adolescent girls and young women in South Africa-study protocol.
    Medina-Marino A; Bezuidenhout D; Hosek S; Barnabas RV; Atujuna M; Bezuidenhout C; Ngwepe P; Peters RPH; Little F; Celum CL; Daniels J; Bekker LG
    Trials; 2021 Jul; 22(1):489. PubMed ID: 34311754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Centering PrEP: utilizing ADAPT-ITT to inform group PrEP care for sex workers in Chicago.
    Singer RB; Barrow J; Johnson AK; Zemlak J; Crooks N; Abboud S; Bruce D; Green N; Stamps J; Neely J; Sherman SG; Patil CL; Matthews AK
    BMC Public Health; 2024 Jan; 24(1):56. PubMed ID: 38166881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acceptability of HIV Pre-Exposure Prophylaxis Among Transgender Women in India: A Qualitative Investigation.
    Chakrapani V; Shunmugam M; Rawat S; Baruah D; Nelson R; Newman PA
    AIDS Patient Care STDS; 2020 Feb; 34(2):92-98. PubMed ID: 31951490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiological impact and cost-effectiveness of providing long-acting pre-exposure prophylaxis to injectable contraceptive users for HIV prevention in South Africa: a modelling study.
    van Vliet MM; Hendrickson C; Nichols BE; Boucher CA; Peters RP; van de Vijver DA
    J Int AIDS Soc; 2019 Dec; 22(12):e25427. PubMed ID: 31855323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Review of Pre-Exposure Prophylaxis Adherence among Female Sex Workers.
    Ghayda RA; Hong SH; Yang JW; Jeong GH; Lee KH; Kronbichler A; Solmi M; Stubbs B; Koyanagi A; Jacob L; Oh H; Kim JY; Shin JI; Smith L
    Yonsei Med J; 2020 May; 61(5):349-358. PubMed ID: 32390358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dapivirine vaginal ring for HIV prevention: modelling health outcomes, drug resistance and cost-effectiveness.
    Glaubius R; Ding Y; Penrose KJ; Hood G; Engquist E; Mellors JW; Parikh UM; Abbas UL
    J Int AIDS Soc; 2019 May; 22(5):e25282. PubMed ID: 31074936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How a menu of adherence support strategies facilitated high adherence to HIV prevention products among adolescent girls and young women in sub-Saharan Africa: a mixed methods analysis.
    Roberts ST; Mancuso N; Williams K; Nabunya HK; Mposula H; Mugocha C; Mvinjelwa P; Garcia M; Szydlo DW; Soto-Torres L; Ngure K; Hosek S
    J Int AIDS Soc; 2023 Nov; 26(11):e26189. PubMed ID: 37936551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors motivating female sex workers to initiate pre- exposure prophylaxis for HIV prevention in Zimbabwe.
    Nhamo D; Duma SE; Ojewole EB; Chibanda D; Cowan FM
    PLoS One; 2022; 17(7):e0264470. PubMed ID: 35797351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.